Alto Neuroscience, Inc. (ANRO)

USD 2.08

(-2.35%)

Eps Summary of Alto Neuroscience, Inc.

  • Alto Neuroscience, Inc.'s latest annual eps in 2023 was -1.35 USD , down -25.0% from previous year.
  • Alto Neuroscience, Inc.'s latest quarterly eps in 2024 Q1 was -0.50 USD , down -19.05% from previous quarter.
  • Alto Neuroscience, Inc. reported an annual eps of -1.08 USD in 2022, down -200.0% from previous year.
  • Alto Neuroscience, Inc. reported an annual eps of -0.36 USD in 2021, down 0.0% from previous year.
  • Alto Neuroscience, Inc. reported a quarterly eps of -0.59 USD for 2024 Q2, down -18.0% from previous quarter.
  • Alto Neuroscience, Inc. reported a quarterly eps of -0.32 USD for 2023 Q2, down -18.52% from previous quarter.

Annual Eps Chart of Alto Neuroscience, Inc. (2023 - 2021)

Historical Annual Eps of Alto Neuroscience, Inc. (2023 - 2021)

Year Eps Eps Growth
2023 -1.35 USD -25.0%
2022 -1.08 USD -200.0%
2021 -0.36 USD 0.0%

Peer Eps Comparison of Alto Neuroscience, Inc.

Name Eps Eps Difference
ADC Therapeutics SA -2.94 USD 54.082%
Annovis Bio, Inc. -6.23 USD 78.331%
Biohaven Pharmaceutical Holding Company Ltd. -5.73 USD 76.44%
Ginkgo Bioworks Holdings, Inc. -18.37 USD 92.651%
Nuvation Bio Inc. -0.35 USD -285.714%
Nuvation Bio Inc. -0.35 USD -285.714%
Arcus Biosciences, Inc. -4.15 USD 67.47%
Zymeworks Inc. -1.72 USD 21.512%